Trial Profile
Pilot study of omalizumab in severe atopic dermatitis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Nov 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 16 Nov 2015 New trial record